Factors Affecting Compliance in Faecal Occult Blood Testing: a Cluster Randomized Study of the Faecal Immunochemical Test Versus the Guaiac Faecal Occult Test
Overview
Authors
Affiliations
Objective: To compare the uptake of faecal immunochemical occult blood test (FIT) with guaiac faecal occult blood test (gFOBT) in a screening programme, with specific attention to the demographic and socioeconomic factors that might affect test uptake.
Setting: The Clalit Health Service screening programme, Israel.
Methods: Average-risk individuals aged 50-75 years were randomized into a FIT arm or gFOBT arm using a programme based on the socioeconomic status (SES) of their primary care clinics. G-FOBT was performed with Hemoccult SENSA™ (3 evacuations) and FIT with the OC- MICRO(TM) (3 evacuations, refrigerating mandated). The GLIMMIX model was used.
Results: There were 5,464 and 10,668 eligible participants in the FIT and gFOBT arms respectively. Compliance in taking the kits was better (but not statistically significantly better) with gFOBT (37.8% vs. 29.3%; odds ratio [OR] 1.43 [95% CI 0.73-2.80]; P = 0.227). Kit return was higher in the FIT arm (65.0% vs. 78.9%; OR 0.45 [95% CI 0.24-0.83], P = 0.021). Overall test uptake was affected by age, gender, being immigrant and SES (determined by whether or not the participant paid national insurance tax, and the SES of the primary care clinic). The overall uptake of gFOBT and FIT was comparable (OR 0.996 [95% CI 0.46-2.17], P = 0.99).
Conclusions: Overall compliance for test uptake was comparable between the two methods despite the more demanding procedure in the FIT arm. Sociodemographic parameters were the major determinants of compliance. An educational programme, with emphasis on the sociodemographic characteristics of the target population, should be instigated.
Rat C, Pogu C, Le Donne D, Latour C, Bianco G, Nanin F JAMA. 2017; 318(9):816-824.
PMID: 28873160 PMC: 5817465. DOI: 10.1001/jama.2017.11387.
Kearns B, Whyte S, Seaman H, Snowball J, Halloran S, Butler P Br J Cancer. 2016; 114(3):327-33.
PMID: 26766733 PMC: 4742589. DOI: 10.1038/bjc.2015.469.
Wang H, Tso V, Wong C, Sadowski D, Fedorak R Clin Transl Gastroenterol. 2014; 5:e54.
PMID: 24646506 PMC: 3940838. DOI: 10.1038/ctg.2014.2.
Uptake and positive predictive value of fecal occult blood tests: A randomized controlled trial.
Chubak J, Bogart A, Fuller S, Laing S, Green B Prev Med. 2013; 57(5):671-8.
PMID: 24029556 PMC: 3856243. DOI: 10.1016/j.ypmed.2013.08.032.
Use of fecal immunochemical tests in the Iowa Research Network.
Daly J, Bay C, Levy B J Cancer Educ. 2013; 28(3):397-401.
PMID: 23686686 PMC: 3755054. DOI: 10.1007/s13187-012-0439-8.